Endometrial cancer is the most prevalent form of gynecologic cancer in the United States,
and the annual incidence rates are only expected to continue rising. The majority of women …

Serous endometrial cancer represents a relative rare entity accounting for about 10% of all
diagnosed endometrial cancer, but it is responsible for 40% of endometrial cancer-related …

Highlights•This ESMO Clinical Practice Guideline provides key recommendations for
managing endometrial cancer.•The guideline covers clinical and pathological diagnosis …

A European consensus conference on endometrial carcinoma was held in 2014 to produce
multi-disciplinary evidence-based guidelines on selected questions. Given the large body of …

Simple Summary Endometrial cancer has a high epidemiological impact, and its
management is part of everyday clinical practice. International guidelines have been …

Simple Summary There are currently no blood biomarkers approved for routine clinical use
in endometrial cancer. Serum human epididymis protein 4 (HE4) is significantly higher in …

Simple Summary New data, the development of new methods of treatment and management
and the rising incidence of endometrial cancer require constant reviewing, in order to inform …

Objective A sentinel lymph node biopsy is widely accepted as the standard of care for
surgical staging in low-grade endometrial cancer, but its value in high-grade endometrial …

Objective To assess oncologic outcomes in endometrial cancer patients with low-volume
metastasis (LVM) in the sentinel lymph nodes (SLNs). Methods Patients with endometrial …

Endometrial cancer (EC) is known as a common gynecological malignancy. The incidence
rate is on the increase annually. Lymph node status plays a crucial role in evaluating the …